| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9347 |
| Human Intestinal Absorption | HIA+ | 0.9961 |
| Caco-2 Permeability | Caco2+ | 0.9305 |
| P-glycoprotein Substrate | Non-substrate | 0.7930 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9430 |
| Non-inhibitor | 0.9619 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8423 |
| Distribution |
| Subcellular localization | Lysosome | 0.4761 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7951 |
| CYP450 2D6 Substrate | Non-substrate | 0.8547 |
| CYP450 3A4 Substrate | Non-substrate | 0.6917 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.5865 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9721 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.5159 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7056 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9541 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8273 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9374 |
| Non-inhibitor | 0.9607 |
| AMES Toxicity | Non AMES toxic | 0.9580 |
| Carcinogens | Non-carcinogens | 0.7658 |
| Fish Toxicity | Low FHMT | 0.7468 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9039 |
| Honey Bee Toxicity | High HBT | 0.5144 |
| Biodegradation | Ready biodegradable | 0.5118 |
| Acute Oral Toxicity | III | 0.8982 |
| Carcinogenicity (Three-class) | Non-required | 0.7665 |